Adverse events33

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 33 of 33

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Asthenia	General disorders	Ontamalimab 75 mg	1	112	1
serious	Pneumonia	Infections and infestations	Placebo	0	56	0
serious	Pneumonia	Infections and infestations	Ontamalimab 25 mg	1	111	1
serious	Pneumonia	Infections and infestations	Ontamalimab 75 mg	0	112	0
serious	Rash pustular	Infections and infestations	Placebo	0	56	0
serious	Rash pustular	Infections and infestations	Ontamalimab 25 mg	1	111	1
serious	Rash pustular	Infections and infestations	Ontamalimab 75 mg	0	112	0
serious	Headache	Nervous system disorders	Placebo	0	56	0
serious	Headache	Nervous system disorders	Ontamalimab 25 mg	1	111	1
serious	Headache	Nervous system disorders	Ontamalimab 75 mg	0	112	0
serious	Hydrocalyx	Renal and urinary disorders	Placebo	1	56	1
serious	Hydrocalyx	Renal and urinary disorders	Ontamalimab 25 mg	0	111	0
serious	Hydrocalyx	Renal and urinary disorders	Ontamalimab 75 mg	0	112	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03259308/events?page=2